发明授权
US5837255A Method of reducing blood glucose by administering Harunganin or Vismin
失效
通过施用Harunganin或Vismin降低血糖的方法
- 专利标题： Method of reducing blood glucose by administering Harunganin or Vismin
- 专利标题（中）： 通过施用Harunganin或Vismin降低血糖的方法
-
申请号： US762785申请日： 1996-12-10
-
公开(公告)号： US5837255A公开(公告)日： 1998-11-17
- 发明人: Wayne DeWald Inman , Jian Luo
- 申请人： Wayne DeWald Inman , Jian Luo
- 申请人地址： CA South San Francisco
- 专利权人： Shaman Pharmaceuticals, Inc.
- 当前专利权人： Shaman Pharmaceuticals, Inc.
- 当前专利权人地址： CA South San Francisco
- 主分类号： A61K31/155
- IPC分类号： A61K31/155 ; A61K31/40 ; A61K31/425 ; A61K31/495 ; A61K31/55 ; A61K31/64 ; A61K31/70 ; A61K36/38 ; A61K38/28 ; A61K35/78 ; A61K31/12 ; C07C50/18
摘要：
The use of extracts from Harungana or Vismia spp. or anthracenone compounds harunganin and vismin contained therein or isolated therefrom as hypoglycemic agents, as well as methods for obtaining the hypoglycemic agents are described. According to a preferred embodiment, the extracts are derived from H. madagascariensis. As hypoglycemic agents, the extracts or anthracenone compounds harunganin and vismin are useful for treating insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.
公开/授权文献
- USD295435S Ski 公开/授权日：1988-04-26
信息查询
